Search Results

Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/ Rifapentine.

• Authors : Brooks, Kristina M.; Pau, Alice K.; Swaim, Doris

• Source: JAIDS: Journal of Acquired Immune Deficiency Syndromes. 12/15/2023, Vol. 94 Issue 5, p468-473. 6p.

Record details

Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV.

• Authors : Momper, Jeremiah D. PharmD, (AUTHOR); Wang, Jiajia MS (AUTHOR); Stek, Alice (AUTHOR)

• Source: JAIDS: Journal of Acquired Immune Deficiency Syndromes. Mar2022, Vol. 89 Issue 3, p303-309. 7p.

Record details

Dyslipidaemia after switch to tenofovir alafenamide (TAF)‐based cART regimens in a cohort of HIV‐positive patients: what clinical relevance?

• Authors : Gazzola, L; Tagliaferri, G; De Bona, A

Subjects: CARDIOVASCULAR diseases risk factors; COMBINATION drug therapy; CONFIDENCE intervals

• Source: HIV Medicine. Feb2021, Vol. 22 Issue 2, p140-145. 6p.

Record details

Application of a microdosed cocktail of 3 oral factor Xa inhibitors to study drug–drug interactions with different perpetrator drugs.

• Authors : Mikus, Gerd (AUTHOR); Foerster, Kathrin I. (AUTHOR); Schaumaeker, Marlene (AUTHOR)

Subjects: TANDEM mass spectrometry; APIXABAN; RIFAMPIN

• Source: British Journal of Clinical Pharmacology. Aug2020, Vol. 86 Issue 8, p1632-1641. 10p. 1 Diagram, 4 Charts, 3 Graphs.

Record details

Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy.

• Authors : Salama, Engie; Eke, Ahizechukwu C.; Best, Brookie M.

Subjects: ANTIRETROVIRAL agents; RITONAVIR; PREGNANCY

• Source: Journal of Clinical Pharmacology. Dec2020, Vol. 60 Issue 12, p1537-1550. 14p.

Record details

Cobicistat as a Pharmacoenhancer in Pregnancy and Postpartum: Progress to Date and Next Steps.

• Authors : Eke, Ahizechukwu C.; Mirochnick, Mark H.

Subjects: COMBINATION drug therapy; GLYCOPROTEINS; PEPTIDES

• Source: Journal of Clinical Pharmacology. Jun2019, Vol. 59 Issue 6, p779-783. 5p.

Record details

Reduced exposure to darunavir and cobicistat in HIV‐1‐infected pregnant women receiving a darunavir/cobicistat‐based regimen.

• Authors : Crauwels, HM (AUTHOR); Osiyemi, O (AUTHOR); Zorrilla, C (AUTHOR)

Subjects: COMBINATION drug therapy; COMPARATIVE studies; GESTATIONAL age

• Source: HIV Medicine. May2019, Vol. 20 Issue 5, p337-343. 7p.

Record details

Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.

• Authors : Marzolini, Catia; Decosterd, Laurent; Winterfeld, Ursula

Subjects: PHARMACOKINETICS; HIV-positive women; MATERNAL health

• Source: British Journal of Clinical Pharmacology. Dec2017, Vol. 83 Issue 12, p2835-2838. 4p. 1 Chart, 1 Graph.

Record details

Pharmacokinetics of darunavir in fixed-dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers.

• Authors : Kakuda, Thomas N.; Opsomer, Magda; Timmers, Maarten

Subjects: BIOAVAILABILITY; CARBOXYLIC acids; COMBINATION drug therapy

• Source: Journal of Clinical Pharmacology. Aug2014, Vol. 54 Issue 8, p949-957. 9p.

Record details

The Pharmacokinetic and Pharmacodynamic Interactions Between Buprenorphine/Naloxone and Elvitegravir/Cobicistat in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment.

• Authors : Bruce, Robert Douglas; Winkle, Peter; Custodio, Joseph M.

• Source: JAIDS: Journal of Acquired Immune Deficiency Syndromes. 8/1/2013, Vol. 63 Issue 4, p480-484. 5p.

Record details